Renin angiotensin system (RAS) blockade by either ACE inhibitors or angiotensin II receptor blockers (ARBs) is associated with a reduced risk of AF in patients with hypertension or heart failure [5,6]. The gene discussed is ACE; the disease is hypertensive disorder.